Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. - Wikidata - awgldk - TriplyDB

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

http://www.wikidata.org/entity/Q45569255

about

Pleiotropic effects of statins in the diseases of the liver Bacterial infections in cirrhosis: A critical review and practical guidance Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis.Markers of bacterial translocation in end-stage liver disease Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis Beta-blockers in liver cirrhosis Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava)Alcoholic liver disease: the gut microbiome and liver cross talk Implication of the intestinal microbiome in complications of cirrhosis The digestive tract as the origin of systemic inflammation Gut Microbiota and Host Reaction in Liver Diseases Non-invasive diagnosis of hepatitis B virus-related cirrhosis Underestimation of liver-related mortality in the United States.A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients.New determinants of prognosis in bacterial infections in cirrhosis.Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.Clinical relevance of sarcopenia in patients with cirrhosis.Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic?Molecular detection of monocyte chemotactic protein-1 polymorphism in spontaneous bacterial peritonitis patients.Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.Integration of palliative care in end-stage liver disease and liver transplantation High mortality of pneumonia in cirrhotic patients with ascites.External validation of bloodstream infection mortality risk score in a population-based cohort.Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.Altered profile of human gut microbiome is associated with cirrhosis and its complications.The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis.The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection.Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease.Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.Investigation of Bacteremia due to Aeromonas Species and Comparison with That due to Enterobacteria in Patients with Liver Cirrhosis.

P2860

Q26741176-A389DB1F-D5CE-4C14-9DB5-7763202CDFC9 Q26766663-09C14619-D08E-4523-9EAF-39C2F8C8B8EE Q26778064-6F50DC45-5FB0-4379-BAB9-0FE4A21AF841 Q26780309-11F45CCE-1F2A-45F9-9004-730F4E913EFC Q26783888-B0D1675F-258C-4D67-8D2C-89F0EE59AAE7 Q26826919-6B73B6A9-7E1C-4417-BB4F-7194E797D709 Q26864558-BD2E8D00-BD2F-4D01-92A9-28D01AD9693C Q27009006-1FF51A18-84BB-4754-BC9D-F990A40DA696 Q27009164-FF719FA9-F86B-4F9B-A8D5-248341AFD0B9 Q27012922-3EA8E3C3-BA3A-4C32-B822-D84060C38725 Q27024792-F6565887-4973-4AB3-9D70-190DE7ADA830 Q27025627-4D8D0F9C-3F49-4F60-80B6-9A173752B408 Q28068832-055A7DDE-AE19-46E4-A198-60B25B59157D Q28076873-4CD7C8EF-3337-49F8-9E0E-18B6C4FAA738 Q28083295-049DBA6C-FA9F-4E9E-BB92-416A9D0B0870 Q30442641-2A5CF42E-69B3-4CCD-8CE4-EEA9E64490BE Q30564165-7B370D24-BA2D-4BC3-8EBE-717566EB76BE Q33638900-2DD321B5-444B-48E2-8858-EB0A39A7869C Q33701184-6ECAC591-030D-4990-B13C-45849082DD40 Q33780129-F9902564-BD6E-48D9-929C-51D4EF66FAFC Q33831448-E9635CBD-DEC3-4225-8FC5-2EA082870CE5 Q33845474-A12CDC32-0555-4AB6-AB03-F41B4E0EFD86 Q33910015-F611E731-138E-40DA-8578-7E977F3B7D7D Q34137375-8B93C773-9A39-4FC5-BB25-BEC0B78D3A9F Q34450128-FAE775A5-8E2A-42D4-ACB8-B103856123CA Q34499979-760C3717-6FD7-4E3D-9949-6595CCA4F71B Q34580244-E407E3C0-4ED0-473B-8366-3D458EAD5B6A Q34626330-A81A1619-97BA-428D-AE42-24E84C4E7BA6 Q34708289-38DC5378-C406-420C-96E3-E5D580EABB80 Q34861969-6021B5D7-5F87-4B69-A443-A592EE1B2F6A Q35077209-7655CDFE-8345-46D2-894D-5D5C8B69A973 Q35170336-6A99CB1A-479D-4CCE-825A-020B7FADBE17 Q35177083-2D5354D5-28B2-406C-9F28-533D657EC9F6 Q35189328-62F71BE4-8A39-4A9F-AF84-74178DC42D7D Q35221810-9D71CC8A-9836-412A-984B-FB4301DEF534 Q35553704-F02EC693-0EE6-43F3-B3A0-C304C6D5F131 Q35587116-39189849-8522-4628-A14D-8EBBFCD1D6C5 Q35647592-674B8611-50C7-42B3-BFF6-AB78E583D7E5 Q35651447-28178951-20D2-481B-A1DF-8CC15DAC9EF8 Q35664101-7FFDDF70-75CF-405B-BB35-D57EDB1B1B20

P2860

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

http://www.wikidata.org/entity/Q45569255

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Infections in patients with ci ...... used in determining prognosis.

@en

Infections in patients with ci ...... used in determining prognosis.

@nl

type

label

Infections in patients with ci ...... used in determining prognosis.

@en

Infections in patients with ci ...... used in determining prognosis.

@nl

prefLabel

Infections in patients with ci ...... used in determining prognosis.

@en

Infections in patients with ci ...... used in determining prognosis.

@nl

P1433

Q45569255-2B2CC976-154F-49FB-BE9B-FD1DA0B361EA

P1476

Q45569255-C6212F7A-820C-4419-A8F3-237E91102442

P2093

Q45569255-16FB14D9-DEA9-4C6E-9F25-9EAA297EC85D

Q45569255-1E83F8E8-D557-4A72-A732-E6B1321BAD37

Q45569255-471B44BA-375D-40BE-BFF1-16B7433D3EF8

Q45569255-48BC1068-EF81-4BAE-8A45-6DF39FE7CA23

Q45569255-7B72B850-73D5-4064-8768-3B4343948342

Q45569255-BE9C61CE-5BDC-4619-8979-74134BB0BB56

P304

Q45569255-4114D9EE-EEB4-4F41-B6DC-A2B91CDF740F

P31

Q45569255-45CC6F3F-2A52-400C-B2F7-81E1E2631FC6

P356

Q45569255-B50AA3FA-C8B0-405E-A898-5AAA0E6AE8C3

P407

Q45569255-9F57E4BF-585B-4118-93DF-14A54BB47AAA

P433

Q45569255-8FAFBE35-F03A-43FE-9B9D-DBE4B8D8D1FD

P478

Q45569255-B22D4212-2B73-42D5-948F-9FB5F7F6B913

P50

Q45569255-DA1A0E9C-7689-447C-B87D-EC2EF83EEA92

P577

Q45569255-C6B03FCD-1D3B-4120-85B1-AE056A970B2D

P5875

Q45569255-C30C1BED-36B8-4DBB-83CD-B299A34A372A

P698

Q45569255-BF8D7AF9-7197-4BDC-BD6D-E9A14C922516

P921

Q45569255-90D167D5-2621-4D67-9582-57CD8C3887AD

P356

J.GASTRO.2010.06.019

P1433

Gastroenterology

P1476

Infections in patients with ci ...... used in determining prognosis.

@en

P2093

Andrew Kenneth Burroughs

http://www.w3.org/2001/XMLSchema#string

Gennaro D'Amico

http://www.w3.org/2001/XMLSchema#string

Giuseppe Fede

http://www.w3.org/2001/XMLSchema#string

Maria Pleguezuelo

http://www.w3.org/2001/XMLSchema#string

Pinelopi Manousou

http://www.w3.org/2001/XMLSchema#string

Vasiliki Arvaniti

http://www.w3.org/2001/XMLSchema#string

P304

1246-56, 1256.e1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2010.06.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Tsochatzis

P577

2010-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44682910

http://www.w3.org/2001/XMLSchema#string

P698

20558165

http://www.w3.org/2001/XMLSchema#string

P921